CNY 13.12
(-2.31%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 4.79 Billion | 3.15 Billion | 3.67 Billion | 3.3 Billion | 2.96 Billion | 1.57 Billion |
Net Income | 2.22 Billion | 3.73 Billion | 3.47 Billion | 1.96 Billion | 1.42 Billion | 991.62 Million |
Depreciation & Amortization | 1.78 Billion | 1.48 Billion | 1.24 Billion | 1.07 Billion | 1.04 Billion | 809.34 Million |
Deferred income taxes | 39.55 Million | -144.8 Million | -11.47 Million | -12.5 Million | 2.34 Million | 10.82 Million |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -352.03 Million | -1.56 Billion | -927.36 Million | -438.16 Million | -4.08 Million | -590.02 Million |
Other non-cash items | 5.02 Billion | -490.8 Million | -123.6 Million | 694.06 Million | 502.06 Million | 367.73 Million |
Investing Cash Flow | -7.39 Billion | -3.66 Billion | -1.55 Billion | -1.99 Billion | -3.28 Billion | -1.73 Billion |
Investments in PPE | -7.76 Billion | -4.53 Billion | -1.8 Billion | -2.7 Billion | -2.17 Billion | -1.7 Billion |
Acquisitions | 248.52 Million | 9.75 Million | 110.59 Million | -33.08 Million | -1.04 Billion | 44.68 Million |
Investment purchases | -1.2 Billion | -500 Million | -33.7 Million | -245.13 Million | -205.11 Million | -81.67 Million |
Sales/Maturities of investments | 1.32 Billion | 18.59 Million | 119.66 Million | 2.04 Million | 29.25 Million | 119.69 Million |
Other Investing Activities | 1.00 | 1.34 Billion | 53.85 Million | 989.78 Million | 116.52 Million | -106.05 Million |
Financing Cash Flow | 216.37 Million | 3.58 Billion | -2.35 Billion | 94.06 Million | 719.31 Million | 15.49 Million |
Debt repayment | -2.63 Billion | -9.48 Billion | -6.8 Billion | -8.45 Billion | -6.26 Billion | -6.38 Billion |
Dividends payments | -1.1 Billion | -1.12 Billion | -671.24 Million | -436.31 Million | -313.68 Million | -489.66 Million |
Common Stock Repurchased | - | - | -1.1 Billion | - | - | - |
Common Stock Issuance | - | - | 1.09 Billion | - | - | - |
Other Financing Activities | 3.96 Billion | 14.59 Billion | 5.59 Billion | 9.49 Billion | 7.71 Billion | 6.89 Billion |
Accounts receivables | -145.36 Million | -759.48 Million | -1.1 Billion | -1.51 Billion | -517.27 Million | -453.73 Million |
Accounts payables | 143.5 Million | 321.88 Million | 187.23 Million | 1.03 Billion | 853.45 Million | -289.98 Million |
Inventory | -350.16 Million | -980.95 Million | 628.82 Thousand | -85.29 Million | -342.61 Million | 140.83 Million |
Other working capital | 183.06 Million | -144.8 Million | -11.47 Million | 123.24 Million | 2.34 Million | -730.86 Million |
Cash at beginning of period | 5.9 Billion | 2.53 Billion | 2.79 Billion | 1.4 Billion | 996.42 Million | 1.12 Billion |
Cash at end of period | 3.54 Billion | 5.65 Billion | 2.53 Billion | 2.77 Billion | 1.4 Billion | 986.76 Million |
Capital Expenditure | -7.76 Billion | -4.53 Billion | -1.8 Billion | -2.7 Billion | -2.17 Billion | -1.7 Billion |
Effect of forex changes on cash | 19.38 Million | 31.32 Million | -22.32 Million | -30.1 Million | -1.54 Million | 4.8 Million |
Net cash flow / Change in cash | -2.36 Billion | 3.11 Billion | -257.63 Million | 1.37 Billion | 405.81 Million | -133.42 Million |
Free Cash Flow | -2.96 Billion | -1.37 Billion | 1.86 Billion | 595.18 Million | 792.88 Million | -130.37 Million |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 143.68 Million | 248.43 Million | 216.24 Million | 2.22 Billion | 516.22 Million | 316.15 Million |
Depreciation & Amortization | - | 521.5 Million | 521.5 Million | 1.78 Billion | 454.74 Million | -859.49 Million |
Deferred income taxes | - | - | - | 39.55 Million | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | 302.07 Million | - | -352.03 Million | -495.53 Million | 3.41 Billion |
Other non-cash items | 1.77 Billion | 2 Billion | -1.97 Billion | 5.02 Billion | 3.53 Billion | -2.95 Billion |
Investing Cash Flow | -818.08 Million | -1.57 Billion | -1.62 Billion | -7.39 Billion | -2.06 Billion | -2.28 Billion |
Investments in PPE | -819.8 Million | -1.63 Billion | -1.63 Billion | -7.76 Billion | -2.18 Billion | -2.13 Billion |
Acquisitions | 720.62 Thousand | 53.37 Million | 12.79 Million | 248.52 Million | -69.5 Million | 73.59 Million |
Investment purchases | - | - | - | -1.2 Billion | -120.89 Million | -268.53 Million |
Sales/Maturities of investments | 1.37 Million | - | - | 1.32 Billion | 313.11 Million | 64.25 Million |
Other Investing Activities | 339.86 Thousand | -359.46 Thousand | 12.79 Million | 1.00 | -1.00 | -24.62 Million |
Financing Cash Flow | -990.38 Million | -326.55 Million | 1.7 Billion | 216.37 Million | -212.3 Million | 379.7 Million |
Debt repayment | -837.47 Million | -850.65 Million | -1.89 Billion | -2.63 Billion | -4.92 Million | -673.03 Million |
Dividends payments | -405.63 Million | -1.17 Billion | -184.71 Million | -1.1 Billion | -820.99 Million | -972.52 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -558.54 Million | -1.17 Billion | -184.71 Million | 3.96 Billion | 613.61 Million | 2.02 Billion |
Accounts receivables | - | 968.97 Million | - | -145.36 Million | -145.36 Million | 2.42 Billion |
Accounts payables | - | - | - | 143.5 Million | - | - |
Inventory | - | -666.89 Million | - | -350.16 Million | -350.16 Million | 990.69 Million |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | 1.52 Billion | 1.76 Billion | 3.54 Billion | 5.9 Billion | 1.44 Billion | 3.11 Billion |
Cash at end of period | 1.62 Billion | 1.57 Billion | 1.76 Billion | 3.54 Billion | 3.54 Billion | 1.11 Billion |
Capital Expenditure | -819.8 Million | -1.63 Billion | -1.63 Billion | -7.76 Billion | -2.18 Billion | -2.13 Billion |
Effect of forex changes on cash | 1.81 Million | 7.65 Million | 3.65 Million | 19.38 Million | -306.13 Thousand | -2.07 Million |
Net cash flow / Change in cash | 107.97 Million | -192.59 Million | -1.77 Billion | -2.36 Billion | 2.09 Billion | -1.99 Billion |
Free Cash Flow | 1.09 Billion | 106.55 Million | -3.39 Billion | -2.96 Billion | 2.32 Billion | -2.21 Billion |
4406
MEDXF
MKC-V
EBRPF
SHANF
007070